These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15814363)

  • 1. Induction of acute lung injury after intranasal administration of toxin botulinum a complex.
    Taysse L; Daulon S; Calvet J; Delamanche S; Hilaire D; Bellier B; Breton P
    Toxicol Pathol; 2005; 33(3):336-42. PubMed ID: 15814363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72.
    Kende M; Tan X; Wlazlowski C; Williams R; Lindsey C; Del Giudice G
    Vaccine; 2007 Apr; 25(16):3219-27. PubMed ID: 17343960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
    Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
    Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant.
    Kende M; Del Giudice G; Rivera N; Hewetson J
    Vaccine; 2006 Mar; 24(12):2213-21. PubMed ID: 16325310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate.
    Yu YZ; Li N; Zhu HQ; Wang RL; Du Y; Wang S; Yu WY; Sun ZW
    Vaccine; 2009 May; 27(21):2816-22. PubMed ID: 19428892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel neurotoxoid vaccine prevents mucosal botulism.
    Kobayashi R; Kohda T; Kataoka K; Ihara H; Kozaki S; Pascual DW; Staats HF; Kiyono H; McGhee JR; Fujihashi K
    J Immunol; 2005 Feb; 174(4):2190-5. PubMed ID: 15699151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress toward development of an inhalation vaccine against botulinum toxin.
    Park JB; Simpson LL
    Expert Rev Vaccines; 2004 Aug; 3(4):477-87. PubMed ID: 15270652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
    Wen SX; Teel LD; Judge NA; O'Brien AD
    Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved method for development of toxoid vaccines and antitoxins.
    Jones RG; Liu Y; Rigsby P; Sesardic D
    J Immunol Methods; 2008 Aug; 337(1):42-8. PubMed ID: 18571196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis.
    Cowan GJ; Atkins HS; Johnson LK; Titball RW; Mitchell TJ
    Vaccine; 2007 Oct; 25(41):7197-205. PubMed ID: 17765365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulism and vaccines for its prevention.
    Smith LA
    Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3.
    Webb RP; Smith TJ; Wright P; Brown J; Smith LA
    Vaccine; 2009 Jul; 27(33):4490-7. PubMed ID: 19450643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A.
    Yu YZ; Zhang SM; Sun ZW; Wang S; Yu WY
    Vaccine; 2007 Dec; 25(52):8843-50. PubMed ID: 18022294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of botulinum toxin activity: evaluation of the lethality assay.
    Pearce LB; Borodic GE; First ER; MacCallum RD
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):69-77. PubMed ID: 8079356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse model of paraquat-poisoned lungs and its gene expression profile.
    Tomita M; Okuyama T; Katsuyama H; Miura Y; Nishimura Y; Hidaka K; Otsuki T; Ishikawa T
    Toxicology; 2007 Mar; 231(2-3):200-9. PubMed ID: 17215068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449-859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains.
    Dolimbek GS; Dolimbek BZ; Aoki KR; Atassi MZ
    Immunol Invest; 2005; 34(2):119-42. PubMed ID: 15921155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Study of New Tetravalent (Type A, B, E, and F) Botulinum Toxoid Vaccine Derived from M Toxin in Japan.
    Torii Y; Sugimoto N; Kohda T; Kozaki S; Morokuma K; Horikawa Y; Ginnaga A; Yamamoto A; Takahashi M
    Jpn J Infect Dis; 2017 Jul; 70(4):423-429. PubMed ID: 28250257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of potency tests of a vaccine against Cl. botulinum type C by different methods.
    Pranter W
    Dev Biol Stand; 1976; 32():185-91. PubMed ID: 793914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurogenic responses in rat lungs after nose-only exposure to diesel exhaust.
    Witten ML; Wong SS; Sun NN; Keith I; Kweon CB; Foster DE; Schauer JJ; Sherrill DL
    Res Rep Health Eff Inst; 2005 Jan; (128):1-37; discussion 39-47. PubMed ID: 15916011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.